BlackRock
UBX

BlackRock’s Unity Biotechnology UBX Stock Holding History

BlackRock’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-81,402
Closed -$31.3K – 5608
2025
Q2 		$31.3K Hold
81,402
– – ﹤0.01% 5073
2025
Q1 		$84.7K Hold
81,402
– – ﹤0.01% 4809
2024
Q4 		$79.5K Buy
81,402
+228
+0.3% +$283 ﹤0.01% 4838
2024
Q3 		$119K Sell
81,174
-7,211
-8% -$10.6K ﹤0.01% 4643
2024
Q2 		$119K Sell
88,385
-23,944
-21% -$36.4K ﹤0.01% 4664
2024
Q1 		$184K Sell
112,329
-752
-0.7% -$1.3K ﹤0.01% 4602
2023
Q4 		$218K Sell
113,081
-376
-0.3% -$699 ﹤0.01% 4619
2023
Q3 		$272K Sell
113,457
-1,389
-1% -$3.68K ﹤0.01% 4590
2023
Q2 		$293K Buy
114,846
+7,350
+7% +$19.4K ﹤0.01% 4631
2023
Q1 		$175K Buy
107,496
+37,078
+53% +$149K ﹤0.01% 4815
2022
Q4 		$193K Buy
70,418
+14,069
+25% +$40.9K ﹤0.01% 4864
2022
Q3 		$223K Sell
56,349
-1,682
-3% -$10.6K ﹤0.01% 4951
2022
Q2 		$327K Buy
58,031
+996
+2% +$8.31K ﹤0.01% 4900
2022
Q1 		$638K Sell
57,035
-517
-0.9% -$5.8K ﹤0.01% 4811
2021
Q4 		$840K Sell
57,552
-32,511
-36% -$711K ﹤0.01% 4725
2021
Q3 		$2.7M Buy
90,063
+1,806
+2% +$63.7K ﹤0.01% 4188
2021
Q2 		$4.09M Sell
88,257
-196,155
-69% -$9.45M ﹤0.01% 3966
2021
Q1 		$17.1M Sell
284,412
-3,753
-1% -$256K ﹤0.01% 3264
2020
Q4 		$15.1M Buy
288,165
+17,902
+7% +$863K ﹤0.01% 3155
2020
Q3 		$9.35M Sell
270,263
-18,972
-7% -$1.2M ﹤0.01% 3256
2020
Q2 		$25.1M Buy
289,235
+68,434
+31% +$5.07M ﹤0.01% 2682
2020
Q1 		$12.8M Sell
220,801
-132
-0.1% -$8.32K ﹤0.01% 2860
2019
Q4 		$15.9M Buy
220,933
+14,661
+7% +$1.03M ﹤0.01% 3010
2019
Q3 		$12.6M Buy
206,272
+7,011
+4% +$496K ﹤0.01% 3100
2019
Q2 		$18.9M Buy
199,261
+9,418
+5% +$801K ﹤0.01% 2869
2019
Q1 		$15.4M Buy
189,843
+4,755
+3% +$539K ﹤0.01% 2882
2018
Q4 		$30.1M Buy
185,088
+150,891
+441% +$20M ﹤0.01% 2507
2018
Q3 		$5.57M Buy
34,197
+11,103
+48% +$1.83M ﹤0.01% 3479
2018
Q2 		$3.48M Buy
+23,094
New +$3.38M ﹤0.01% 3581

Other funds holding UBX

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

BlackRock's UBX Position: Q3 2025 in Review

BlackRock sold out of Unity Biotechnology (UBX) in Q3 2025, closing a stake of 81,402 shares — an estimated $31.3K sold.

BlackRock first reported a position in UBX in Q2 2018 and held it in 29 quarters. The position peaked at $30.1M in Q4 2018. 6 funds tracked by Wall St. Rank hold UBX as of Q3 2025.

  • BlackRock reported no remaining Unity Biotechnology position as of Q3 2025 after selling out during the quarter.
  • BlackRock sold 81,402 Unity Biotechnology shares in Q3 2025, an estimated $31.3K.
  • BlackRock first reported a position in Unity Biotechnology in Q2 2018 and held it in 29 quarters.
  • BlackRock's Unity Biotechnology position peaked at $30.1M in Q4 2018.
  • 6 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2025.

Based on BlackRock's 13F filing for Q3 2025, filed 12 Nov 2025.